Global Vaccine Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Vaccine market. Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccine market.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or 'wild' pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Key Features:
The report on Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccine market. It may include historical data, market segmentation by Type (e.g., Varicella Vaccine, Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccine industry. This include advancements in Vaccine technology, Vaccine new entrants, Vaccine new investment, and other innovations that are shaping the future of Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccine market.
Market Segmentation:
Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Vaccine market. Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccine market.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or 'wild' pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Key Features:
The report on Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccine market. It may include historical data, market segmentation by Type (e.g., Varicella Vaccine, Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccine industry. This include advancements in Vaccine technology, Vaccine new entrants, Vaccine new investment, and other innovations that are shaping the future of Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccine market.
Market Segmentation:
Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Varicella Vaccine
- Influenza Vaccine
- Polio Vaccine
- Hepatitis A Vaccine
- Rabies Vaccine
- BCG Vaccine
- Hepatitis B
- Pertussis, Diphtheria, Tetanus
- Pneumococcal
- Others
- For Adult
- For Child
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- BioNTech
- Boehringer-Ingelheim
- CCBIO
- CSL
- CureVac
- Elanco
- GSK
- Hulan Bio
- Indian Immunologicals
- Merck
- Minhai Biotechnology
- Mitsubishi Tanabe Pharma
- Moderna Therapeutics
- Mylan
- Plumbline Life Sciences
- Sanofi
- Translate Bio
- Walvax Biotechnology
- Wuhan Institute of Biological Products
- Zoties
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Market Size 2019-2030
2.1.2 Vaccine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Vaccine Segment by Type
2.2.1 Varicella Vaccine
2.2.2 Influenza Vaccine
2.2.3 Polio Vaccine
2.2.4 Hepatitis A Vaccine
2.2.5 Rabies Vaccine
2.2.6 BCG Vaccine
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.2.10 Others
2.3 Vaccine Market Size by Type
2.3.1 Vaccine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Vaccine Market Size Market Share by Type (2019-2024)
2.4 Vaccine Segment by Application
2.4.1 For Adult
2.4.2 For Child
2.5 Vaccine Market Size by Application
2.5.1 Vaccine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Vaccine Market Size Market Share by Application (2019-2024)
3 VACCINE MARKET SIZE BY PLAYER
3.1 Vaccine Market Size Market Share by Players
3.1.1 Global Vaccine Revenue by Players (2019-2024)
3.1.2 Global Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE BY REGIONS
4.1 Vaccine Market Size by Regions (2019-2024)
4.2 Americas Vaccine Market Size Growth (2019-2024)
4.3 APAC Vaccine Market Size Growth (2019-2024)
4.4 Europe Vaccine Market Size Growth (2019-2024)
4.5 Middle East & Africa Vaccine Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Vaccine Market Size by Country (2019-2024)
5.2 Americas Vaccine Market Size by Type (2019-2024)
5.3 Americas Vaccine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Market Size by Region (2019-2024)
6.2 APAC Vaccine Market Size by Type (2019-2024)
6.3 APAC Vaccine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine by Country (2019-2024)
7.2 Europe Vaccine Market Size by Type (2019-2024)
7.3 Europe Vaccine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine by Region (2019-2024)
8.2 Middle East & Africa Vaccine Market Size by Type (2019-2024)
8.3 Middle East & Africa Vaccine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE MARKET FORECAST
10.1 Global Vaccine Forecast by Regions (2025-2030)
10.1.1 Global Vaccine Forecast by Regions (2025-2030)
10.1.2 Americas Vaccine Forecast
10.1.3 APAC Vaccine Forecast
10.1.4 Europe Vaccine Forecast
10.1.5 Middle East & Africa Vaccine Forecast
10.2 Americas Vaccine Forecast by Country (2025-2030)
10.2.1 United States Vaccine Market Forecast
10.2.2 Canada Vaccine Market Forecast
10.2.3 Mexico Vaccine Market Forecast
10.2.4 Brazil Vaccine Market Forecast
10.3 APAC Vaccine Forecast by Region (2025-2030)
10.3.1 China Vaccine Market Forecast
10.3.2 Japan Vaccine Market Forecast
10.3.3 Korea Vaccine Market Forecast
10.3.4 Southeast Asia Vaccine Market Forecast
10.3.5 India Vaccine Market Forecast
10.3.6 Australia Vaccine Market Forecast
10.4 Europe Vaccine Forecast by Country (2025-2030)
10.4.1 Germany Vaccine Market Forecast
10.4.2 France Vaccine Market Forecast
10.4.3 UK Vaccine Market Forecast
10.4.4 Italy Vaccine Market Forecast
10.4.5 Russia Vaccine Market Forecast
10.5 Middle East & Africa Vaccine Forecast by Region (2025-2030)
10.5.1 Egypt Vaccine Market Forecast
10.5.2 South Africa Vaccine Market Forecast
10.5.3 Israel Vaccine Market Forecast
10.5.4 Turkey Vaccine Market Forecast
10.5.5 GCC Countries Vaccine Market Forecast
10.6 Global Vaccine Forecast by Type (2025-2030)
10.7 Global Vaccine Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Vaccine Product Offered
11.1.3 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech Vaccine Product Offered
11.2.3 BioNTech Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Information
11.3.2 Boehringer-Ingelheim Vaccine Product Offered
11.3.3 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Boehringer-Ingelheim Main Business Overview
11.3.5 Boehringer-Ingelheim Latest Developments
11.4 CCBIO
11.4.1 CCBIO Company Information
11.4.2 CCBIO Vaccine Product Offered
11.4.3 CCBIO Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CCBIO Main Business Overview
11.4.5 CCBIO Latest Developments
11.5 CSL
11.5.1 CSL Company Information
11.5.2 CSL Vaccine Product Offered
11.5.3 CSL Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 CSL Main Business Overview
11.5.5 CSL Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac Vaccine Product Offered
11.6.3 CureVac Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Elanco
11.7.1 Elanco Company Information
11.7.2 Elanco Vaccine Product Offered
11.7.3 Elanco Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Elanco Main Business Overview
11.7.5 Elanco Latest Developments
11.8 GSK
11.8.1 GSK Company Information
11.8.2 GSK Vaccine Product Offered
11.8.3 GSK Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 GSK Main Business Overview
11.8.5 GSK Latest Developments
11.9 Hulan Bio
11.9.1 Hulan Bio Company Information
11.9.2 Hulan Bio Vaccine Product Offered
11.9.3 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Hulan Bio Main Business Overview
11.9.5 Hulan Bio Latest Developments
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Information
11.10.2 Indian Immunologicals Vaccine Product Offered
11.10.3 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Indian Immunologicals Main Business Overview
11.10.5 Indian Immunologicals Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine Product Offered
11.11.3 Merck Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Information
11.12.2 Minhai Biotechnology Vaccine Product Offered
11.12.3 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Minhai Biotechnology Main Business Overview
11.12.5 Minhai Biotechnology Latest Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Information
11.13.2 Mitsubishi Tanabe Pharma Vaccine Product Offered
11.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Mitsubishi Tanabe Pharma Main Business Overview
11.13.5 Mitsubishi Tanabe Pharma Latest Developments
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Information
11.14.2 Moderna Therapeutics Vaccine Product Offered
11.14.3 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Moderna Therapeutics Main Business Overview
11.14.5 Moderna Therapeutics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Vaccine Product Offered
11.15.3 Mylan Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Information
11.16.2 Plumbline Life Sciences Vaccine Product Offered
11.16.3 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Plumbline Life Sciences Main Business Overview
11.16.5 Plumbline Life Sciences Latest Developments
11.17 Sanofi
11.17.1 Sanofi Company Information
11.17.2 Sanofi Vaccine Product Offered
11.17.3 Sanofi Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Sanofi Main Business Overview
11.17.5 Sanofi Latest Developments
11.18 Translate Bio
11.18.1 Translate Bio Company Information
11.18.2 Translate Bio Vaccine Product Offered
11.18.3 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Translate Bio Main Business Overview
11.18.5 Translate Bio Latest Developments
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Information
11.19.2 Walvax Biotechnology Vaccine Product Offered
11.19.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Walvax Biotechnology Main Business Overview
11.19.5 Walvax Biotechnology Latest Developments
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Information
11.20.2 Wuhan Institute of Biological Products Vaccine Product Offered
11.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Wuhan Institute of Biological Products Main Business Overview
11.20.5 Wuhan Institute of Biological Products Latest Developments
11.21 Zoties
11.21.1 Zoties Company Information
11.21.2 Zoties Vaccine Product Offered
11.21.3 Zoties Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Zoties Main Business Overview
11.21.5 Zoties Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Market Size 2019-2030
2.1.2 Vaccine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Vaccine Segment by Type
2.2.1 Varicella Vaccine
2.2.2 Influenza Vaccine
2.2.3 Polio Vaccine
2.2.4 Hepatitis A Vaccine
2.2.5 Rabies Vaccine
2.2.6 BCG Vaccine
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.2.10 Others
2.3 Vaccine Market Size by Type
2.3.1 Vaccine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Vaccine Market Size Market Share by Type (2019-2024)
2.4 Vaccine Segment by Application
2.4.1 For Adult
2.4.2 For Child
2.5 Vaccine Market Size by Application
2.5.1 Vaccine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Vaccine Market Size Market Share by Application (2019-2024)
3 VACCINE MARKET SIZE BY PLAYER
3.1 Vaccine Market Size Market Share by Players
3.1.1 Global Vaccine Revenue by Players (2019-2024)
3.1.2 Global Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE BY REGIONS
4.1 Vaccine Market Size by Regions (2019-2024)
4.2 Americas Vaccine Market Size Growth (2019-2024)
4.3 APAC Vaccine Market Size Growth (2019-2024)
4.4 Europe Vaccine Market Size Growth (2019-2024)
4.5 Middle East & Africa Vaccine Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Vaccine Market Size by Country (2019-2024)
5.2 Americas Vaccine Market Size by Type (2019-2024)
5.3 Americas Vaccine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Market Size by Region (2019-2024)
6.2 APAC Vaccine Market Size by Type (2019-2024)
6.3 APAC Vaccine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine by Country (2019-2024)
7.2 Europe Vaccine Market Size by Type (2019-2024)
7.3 Europe Vaccine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine by Region (2019-2024)
8.2 Middle East & Africa Vaccine Market Size by Type (2019-2024)
8.3 Middle East & Africa Vaccine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE MARKET FORECAST
10.1 Global Vaccine Forecast by Regions (2025-2030)
10.1.1 Global Vaccine Forecast by Regions (2025-2030)
10.1.2 Americas Vaccine Forecast
10.1.3 APAC Vaccine Forecast
10.1.4 Europe Vaccine Forecast
10.1.5 Middle East & Africa Vaccine Forecast
10.2 Americas Vaccine Forecast by Country (2025-2030)
10.2.1 United States Vaccine Market Forecast
10.2.2 Canada Vaccine Market Forecast
10.2.3 Mexico Vaccine Market Forecast
10.2.4 Brazil Vaccine Market Forecast
10.3 APAC Vaccine Forecast by Region (2025-2030)
10.3.1 China Vaccine Market Forecast
10.3.2 Japan Vaccine Market Forecast
10.3.3 Korea Vaccine Market Forecast
10.3.4 Southeast Asia Vaccine Market Forecast
10.3.5 India Vaccine Market Forecast
10.3.6 Australia Vaccine Market Forecast
10.4 Europe Vaccine Forecast by Country (2025-2030)
10.4.1 Germany Vaccine Market Forecast
10.4.2 France Vaccine Market Forecast
10.4.3 UK Vaccine Market Forecast
10.4.4 Italy Vaccine Market Forecast
10.4.5 Russia Vaccine Market Forecast
10.5 Middle East & Africa Vaccine Forecast by Region (2025-2030)
10.5.1 Egypt Vaccine Market Forecast
10.5.2 South Africa Vaccine Market Forecast
10.5.3 Israel Vaccine Market Forecast
10.5.4 Turkey Vaccine Market Forecast
10.5.5 GCC Countries Vaccine Market Forecast
10.6 Global Vaccine Forecast by Type (2025-2030)
10.7 Global Vaccine Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Vaccine Product Offered
11.1.3 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech Vaccine Product Offered
11.2.3 BioNTech Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Information
11.3.2 Boehringer-Ingelheim Vaccine Product Offered
11.3.3 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Boehringer-Ingelheim Main Business Overview
11.3.5 Boehringer-Ingelheim Latest Developments
11.4 CCBIO
11.4.1 CCBIO Company Information
11.4.2 CCBIO Vaccine Product Offered
11.4.3 CCBIO Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CCBIO Main Business Overview
11.4.5 CCBIO Latest Developments
11.5 CSL
11.5.1 CSL Company Information
11.5.2 CSL Vaccine Product Offered
11.5.3 CSL Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 CSL Main Business Overview
11.5.5 CSL Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac Vaccine Product Offered
11.6.3 CureVac Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Elanco
11.7.1 Elanco Company Information
11.7.2 Elanco Vaccine Product Offered
11.7.3 Elanco Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Elanco Main Business Overview
11.7.5 Elanco Latest Developments
11.8 GSK
11.8.1 GSK Company Information
11.8.2 GSK Vaccine Product Offered
11.8.3 GSK Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 GSK Main Business Overview
11.8.5 GSK Latest Developments
11.9 Hulan Bio
11.9.1 Hulan Bio Company Information
11.9.2 Hulan Bio Vaccine Product Offered
11.9.3 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Hulan Bio Main Business Overview
11.9.5 Hulan Bio Latest Developments
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Information
11.10.2 Indian Immunologicals Vaccine Product Offered
11.10.3 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Indian Immunologicals Main Business Overview
11.10.5 Indian Immunologicals Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine Product Offered
11.11.3 Merck Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Information
11.12.2 Minhai Biotechnology Vaccine Product Offered
11.12.3 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Minhai Biotechnology Main Business Overview
11.12.5 Minhai Biotechnology Latest Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Information
11.13.2 Mitsubishi Tanabe Pharma Vaccine Product Offered
11.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Mitsubishi Tanabe Pharma Main Business Overview
11.13.5 Mitsubishi Tanabe Pharma Latest Developments
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Information
11.14.2 Moderna Therapeutics Vaccine Product Offered
11.14.3 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Moderna Therapeutics Main Business Overview
11.14.5 Moderna Therapeutics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Vaccine Product Offered
11.15.3 Mylan Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Information
11.16.2 Plumbline Life Sciences Vaccine Product Offered
11.16.3 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Plumbline Life Sciences Main Business Overview
11.16.5 Plumbline Life Sciences Latest Developments
11.17 Sanofi
11.17.1 Sanofi Company Information
11.17.2 Sanofi Vaccine Product Offered
11.17.3 Sanofi Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Sanofi Main Business Overview
11.17.5 Sanofi Latest Developments
11.18 Translate Bio
11.18.1 Translate Bio Company Information
11.18.2 Translate Bio Vaccine Product Offered
11.18.3 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Translate Bio Main Business Overview
11.18.5 Translate Bio Latest Developments
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Information
11.19.2 Walvax Biotechnology Vaccine Product Offered
11.19.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Walvax Biotechnology Main Business Overview
11.19.5 Walvax Biotechnology Latest Developments
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Information
11.20.2 Wuhan Institute of Biological Products Vaccine Product Offered
11.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Wuhan Institute of Biological Products Main Business Overview
11.20.5 Wuhan Institute of Biological Products Latest Developments
11.21 Zoties
11.21.1 Zoties Company Information
11.21.2 Zoties Vaccine Product Offered
11.21.3 Zoties Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Zoties Main Business Overview
11.21.5 Zoties Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Varicella Vaccine
Table 3. Major Players of Influenza Vaccine
Table 4. Major Players of Polio Vaccine
Table 5. Major Players of Hepatitis A Vaccine
Table 6. Major Players of Rabies Vaccine
Table 7. Major Players of BCG Vaccine
Table 8. Major Players of Hepatitis B
Table 9. Major Players of Pertussis, Diphtheria, Tetanus
Table 10. Major Players of Pneumococcal
Table 11. Major Players of Others
Table 12. Vaccine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 13. Global Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 14. Global Vaccine Market Size Market Share by Type (2019-2024)
Table 15. Vaccine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 16. Global Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 17. Global Vaccine Market Size Market Share by Application (2019-2024)
Table 18. Global Vaccine Revenue by Players (2019-2024) & ($ Millions)
Table 19. Global Vaccine Revenue Market Share by Player (2019-2024)
Table 20. Vaccine Key Players Head office and Products Offered
Table 21. Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Vaccine Market Size by Regions 2019-2024 & ($ Millions)
Table 25. Global Vaccine Market Size Market Share by Regions (2019-2024)
Table 26. Global Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 27. Global Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 28. Americas Vaccine Market Size by Country (2019-2024) & ($ Millions)
Table 29. Americas Vaccine Market Size Market Share by Country (2019-2024)
Table 30. Americas Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 31. Americas Vaccine Market Size Market Share by Type (2019-2024)
Table 32. Americas Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 33. Americas Vaccine Market Size Market Share by Application (2019-2024)
Table 34. APAC Vaccine Market Size by Region (2019-2024) & ($ Millions)
Table 35. APAC Vaccine Market Size Market Share by Region (2019-2024)
Table 36. APAC Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 37. APAC Vaccine Market Size Market Share by Type (2019-2024)
Table 38. APAC Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 39. APAC Vaccine Market Size Market Share by Application (2019-2024)
Table 40. Europe Vaccine Market Size by Country (2019-2024) & ($ Millions)
Table 41. Europe Vaccine Market Size Market Share by Country (2019-2024)
Table 42. Europe Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 43. Europe Vaccine Market Size Market Share by Type (2019-2024)
Table 44. Europe Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 45. Europe Vaccine Market Size Market Share by Application (2019-2024)
Table 46. Middle East & Africa Vaccine Market Size by Region (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Vaccine Market Size Market Share by Region (2019-2024)
Table 48. Middle East & Africa Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 49. Middle East & Africa Vaccine Market Size Market Share by Type (2019-2024)
Table 50. Middle East & Africa Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 51. Middle East & Africa Vaccine Market Size Market Share by Application (2019-2024)
Table 52. Key Market Drivers & Growth Opportunities of Vaccine
Table 53. Key Market Challenges & Risks of Vaccine
Table 54. Key Industry Trends of Vaccine
Table 55. Global Vaccine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 56. Global Vaccine Market Size Market Share Forecast by Regions (2025-2030)
Table 57. Global Vaccine Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 58. Global Vaccine Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 59. AstraZeneca Details, Company Type, Vaccine Area Served and Its Competitors
Table 60. AstraZeneca Vaccine Product Offered
Table 61. AstraZeneca Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. AstraZeneca Main Business
Table 63. AstraZeneca Latest Developments
Table 64. BioNTech Details, Company Type, Vaccine Area Served and Its Competitors
Table 65. BioNTech Vaccine Product Offered
Table 66. BioNTech Main Business
Table 67. BioNTech Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. BioNTech Latest Developments
Table 69. Boehringer-Ingelheim Details, Company Type, Vaccine Area Served and Its Competitors
Table 70. Boehringer-Ingelheim Vaccine Product Offered
Table 71. Boehringer-Ingelheim Main Business
Table 72. Boehringer-Ingelheim Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Boehringer-Ingelheim Latest Developments
Table 74. CCBIO Details, Company Type, Vaccine Area Served and Its Competitors
Table 75. CCBIO Vaccine Product Offered
Table 76. CCBIO Main Business
Table 77. CCBIO Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. CCBIO Latest Developments
Table 79. CSL Details, Company Type, Vaccine Area Served and Its Competitors
Table 80. CSL Vaccine Product Offered
Table 81. CSL Main Business
Table 82. CSL Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. CSL Latest Developments
Table 84. CureVac Details, Company Type, Vaccine Area Served and Its Competitors
Table 85. CureVac Vaccine Product Offered
Table 86. CureVac Main Business
Table 87. CureVac Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. CureVac Latest Developments
Table 89. Elanco Details, Company Type, Vaccine Area Served and Its Competitors
Table 90. Elanco Vaccine Product Offered
Table 91. Elanco Main Business
Table 92. Elanco Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Elanco Latest Developments
Table 94. GSK Details, Company Type, Vaccine Area Served and Its Competitors
Table 95. GSK Vaccine Product Offered
Table 96. GSK Main Business
Table 97. GSK Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. GSK Latest Developments
Table 99. Hulan Bio Details, Company Type, Vaccine Area Served and Its Competitors
Table 100. Hulan Bio Vaccine Product Offered
Table 101. Hulan Bio Main Business
Table 102. Hulan Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Hulan Bio Latest Developments
Table 104. Indian Immunologicals Details, Company Type, Vaccine Area Served and Its Competitors
Table 105. Indian Immunologicals Vaccine Product Offered
Table 106. Indian Immunologicals Main Business
Table 107. Indian Immunologicals Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Indian Immunologicals Latest Developments
Table 109. Merck Details, Company Type, Vaccine Area Served and Its Competitors
Table 110. Merck Vaccine Product Offered
Table 111. Merck Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Merck Main Business
Table 113. Merck Latest Developments
Table 114. Minhai Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors
Table 115. Minhai Biotechnology Vaccine Product Offered
Table 116. Minhai Biotechnology Main Business
Table 117. Minhai Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Minhai Biotechnology Latest Developments
Table 119. Mitsubishi Tanabe Pharma Details, Company Type, Vaccine Area Served and Its Competitors
Table 120. Mitsubishi Tanabe Pharma Vaccine Product Offered
Table 121. Mitsubishi Tanabe Pharma Main Business
Table 122. Mitsubishi Tanabe Pharma Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Mitsubishi Tanabe Pharma Latest Developments
Table 124. Moderna Therapeutics Details, Company Type, Vaccine Area Served and Its Competitors
Table 125. Moderna Therapeutics Vaccine Product Offered
Table 126. Moderna Therapeutics Main Business
Table 127. Moderna Therapeutics Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Moderna Therapeutics Latest Developments
Table 129. Mylan Details, Company Type, Vaccine Area Served and Its Competitors
Table 130. Mylan Vaccine Product Offered
Table 131. Mylan Main Business
Table 132. Mylan Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Mylan Latest Developments
Table 134. Plumbline Life Sciences Details, Company Type, Vaccine Area Served and Its Competitors
Table 135. Plumbline Life Sciences Vaccine Product Offered
Table 136. Plumbline Life Sciences Main Business
Table 137. Plumbline Life Sciences Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Plumbline Life Sciences Latest Developments
Table 139. Sanofi Details, Company Type, Vaccine Area Served and Its Competitors
Table 140. Sanofi Vaccine Product Offered
Table 141. Sanofi Main Business
Table 142. Sanofi Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Sanofi Latest Developments
Table 144. Translate Bio Details, Company Type, Vaccine Area Served and Its Competitors
Table 145. Translate Bio Vaccine Product Offered
Table 146. Translate Bio Main Business
Table 147. Translate Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Translate Bio Latest Developments
Table 149. Walvax Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors
Table 150. Walvax Biotechnology Vaccine Product Offered
Table 151. Walvax Biotechnology Main Business
Table 152. Walvax Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Walvax Biotechnology Latest Developments
Table 154. Wuhan Institute of Biological Products Details, Company Type, Vaccine Area Served and Its Competitors
Table 155. Wuhan Institute of Biological Products Vaccine Product Offered
Table 156. Wuhan Institute of Biological Products Main Business
Table 157. Wuhan Institute of Biological Products Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 158. Wuhan Institute of Biological Products Latest Developments
Table 159. Zoties Details, Company Type, Vaccine Area Served and Its Competitors
Table 160. Zoties Vaccine Product Offered
Table 161. Zoties Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 162. Zoties Main Business
Table 163. Zoties Latest Developments
Table 1. Vaccine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Varicella Vaccine
Table 3. Major Players of Influenza Vaccine
Table 4. Major Players of Polio Vaccine
Table 5. Major Players of Hepatitis A Vaccine
Table 6. Major Players of Rabies Vaccine
Table 7. Major Players of BCG Vaccine
Table 8. Major Players of Hepatitis B
Table 9. Major Players of Pertussis, Diphtheria, Tetanus
Table 10. Major Players of Pneumococcal
Table 11. Major Players of Others
Table 12. Vaccine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 13. Global Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 14. Global Vaccine Market Size Market Share by Type (2019-2024)
Table 15. Vaccine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 16. Global Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 17. Global Vaccine Market Size Market Share by Application (2019-2024)
Table 18. Global Vaccine Revenue by Players (2019-2024) & ($ Millions)
Table 19. Global Vaccine Revenue Market Share by Player (2019-2024)
Table 20. Vaccine Key Players Head office and Products Offered
Table 21. Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Vaccine Market Size by Regions 2019-2024 & ($ Millions)
Table 25. Global Vaccine Market Size Market Share by Regions (2019-2024)
Table 26. Global Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 27. Global Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 28. Americas Vaccine Market Size by Country (2019-2024) & ($ Millions)
Table 29. Americas Vaccine Market Size Market Share by Country (2019-2024)
Table 30. Americas Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 31. Americas Vaccine Market Size Market Share by Type (2019-2024)
Table 32. Americas Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 33. Americas Vaccine Market Size Market Share by Application (2019-2024)
Table 34. APAC Vaccine Market Size by Region (2019-2024) & ($ Millions)
Table 35. APAC Vaccine Market Size Market Share by Region (2019-2024)
Table 36. APAC Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 37. APAC Vaccine Market Size Market Share by Type (2019-2024)
Table 38. APAC Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 39. APAC Vaccine Market Size Market Share by Application (2019-2024)
Table 40. Europe Vaccine Market Size by Country (2019-2024) & ($ Millions)
Table 41. Europe Vaccine Market Size Market Share by Country (2019-2024)
Table 42. Europe Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 43. Europe Vaccine Market Size Market Share by Type (2019-2024)
Table 44. Europe Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 45. Europe Vaccine Market Size Market Share by Application (2019-2024)
Table 46. Middle East & Africa Vaccine Market Size by Region (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Vaccine Market Size Market Share by Region (2019-2024)
Table 48. Middle East & Africa Vaccine Market Size by Type (2019-2024) & ($ Millions)
Table 49. Middle East & Africa Vaccine Market Size Market Share by Type (2019-2024)
Table 50. Middle East & Africa Vaccine Market Size by Application (2019-2024) & ($ Millions)
Table 51. Middle East & Africa Vaccine Market Size Market Share by Application (2019-2024)
Table 52. Key Market Drivers & Growth Opportunities of Vaccine
Table 53. Key Market Challenges & Risks of Vaccine
Table 54. Key Industry Trends of Vaccine
Table 55. Global Vaccine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 56. Global Vaccine Market Size Market Share Forecast by Regions (2025-2030)
Table 57. Global Vaccine Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 58. Global Vaccine Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 59. AstraZeneca Details, Company Type, Vaccine Area Served and Its Competitors
Table 60. AstraZeneca Vaccine Product Offered
Table 61. AstraZeneca Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. AstraZeneca Main Business
Table 63. AstraZeneca Latest Developments
Table 64. BioNTech Details, Company Type, Vaccine Area Served and Its Competitors
Table 65. BioNTech Vaccine Product Offered
Table 66. BioNTech Main Business
Table 67. BioNTech Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. BioNTech Latest Developments
Table 69. Boehringer-Ingelheim Details, Company Type, Vaccine Area Served and Its Competitors
Table 70. Boehringer-Ingelheim Vaccine Product Offered
Table 71. Boehringer-Ingelheim Main Business
Table 72. Boehringer-Ingelheim Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Boehringer-Ingelheim Latest Developments
Table 74. CCBIO Details, Company Type, Vaccine Area Served and Its Competitors
Table 75. CCBIO Vaccine Product Offered
Table 76. CCBIO Main Business
Table 77. CCBIO Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. CCBIO Latest Developments
Table 79. CSL Details, Company Type, Vaccine Area Served and Its Competitors
Table 80. CSL Vaccine Product Offered
Table 81. CSL Main Business
Table 82. CSL Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. CSL Latest Developments
Table 84. CureVac Details, Company Type, Vaccine Area Served and Its Competitors
Table 85. CureVac Vaccine Product Offered
Table 86. CureVac Main Business
Table 87. CureVac Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. CureVac Latest Developments
Table 89. Elanco Details, Company Type, Vaccine Area Served and Its Competitors
Table 90. Elanco Vaccine Product Offered
Table 91. Elanco Main Business
Table 92. Elanco Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Elanco Latest Developments
Table 94. GSK Details, Company Type, Vaccine Area Served and Its Competitors
Table 95. GSK Vaccine Product Offered
Table 96. GSK Main Business
Table 97. GSK Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. GSK Latest Developments
Table 99. Hulan Bio Details, Company Type, Vaccine Area Served and Its Competitors
Table 100. Hulan Bio Vaccine Product Offered
Table 101. Hulan Bio Main Business
Table 102. Hulan Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Hulan Bio Latest Developments
Table 104. Indian Immunologicals Details, Company Type, Vaccine Area Served and Its Competitors
Table 105. Indian Immunologicals Vaccine Product Offered
Table 106. Indian Immunologicals Main Business
Table 107. Indian Immunologicals Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Indian Immunologicals Latest Developments
Table 109. Merck Details, Company Type, Vaccine Area Served and Its Competitors
Table 110. Merck Vaccine Product Offered
Table 111. Merck Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Merck Main Business
Table 113. Merck Latest Developments
Table 114. Minhai Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors
Table 115. Minhai Biotechnology Vaccine Product Offered
Table 116. Minhai Biotechnology Main Business
Table 117. Minhai Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Minhai Biotechnology Latest Developments
Table 119. Mitsubishi Tanabe Pharma Details, Company Type, Vaccine Area Served and Its Competitors
Table 120. Mitsubishi Tanabe Pharma Vaccine Product Offered
Table 121. Mitsubishi Tanabe Pharma Main Business
Table 122. Mitsubishi Tanabe Pharma Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Mitsubishi Tanabe Pharma Latest Developments
Table 124. Moderna Therapeutics Details, Company Type, Vaccine Area Served and Its Competitors
Table 125. Moderna Therapeutics Vaccine Product Offered
Table 126. Moderna Therapeutics Main Business
Table 127. Moderna Therapeutics Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Moderna Therapeutics Latest Developments
Table 129. Mylan Details, Company Type, Vaccine Area Served and Its Competitors
Table 130. Mylan Vaccine Product Offered
Table 131. Mylan Main Business
Table 132. Mylan Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Mylan Latest Developments
Table 134. Plumbline Life Sciences Details, Company Type, Vaccine Area Served and Its Competitors
Table 135. Plumbline Life Sciences Vaccine Product Offered
Table 136. Plumbline Life Sciences Main Business
Table 137. Plumbline Life Sciences Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Plumbline Life Sciences Latest Developments
Table 139. Sanofi Details, Company Type, Vaccine Area Served and Its Competitors
Table 140. Sanofi Vaccine Product Offered
Table 141. Sanofi Main Business
Table 142. Sanofi Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Sanofi Latest Developments
Table 144. Translate Bio Details, Company Type, Vaccine Area Served and Its Competitors
Table 145. Translate Bio Vaccine Product Offered
Table 146. Translate Bio Main Business
Table 147. Translate Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Translate Bio Latest Developments
Table 149. Walvax Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors
Table 150. Walvax Biotechnology Vaccine Product Offered
Table 151. Walvax Biotechnology Main Business
Table 152. Walvax Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Walvax Biotechnology Latest Developments
Table 154. Wuhan Institute of Biological Products Details, Company Type, Vaccine Area Served and Its Competitors
Table 155. Wuhan Institute of Biological Products Vaccine Product Offered
Table 156. Wuhan Institute of Biological Products Main Business
Table 157. Wuhan Institute of Biological Products Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 158. Wuhan Institute of Biological Products Latest Developments
Table 159. Zoties Details, Company Type, Vaccine Area Served and Its Competitors
Table 160. Zoties Vaccine Product Offered
Table 161. Zoties Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 162. Zoties Main Business
Table 163. Zoties Latest Developments
LIST OF FIGURES
Figure 1. Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Vaccine Sales Market Share by Country/Region (2023)
Figure 8. Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Vaccine Market Size Market Share by Type in 2023
Figure 10. Vaccine in For Adult
Figure 11. Global Vaccine Market: For Adult (2019-2024) & ($ Millions)
Figure 12. Vaccine in For Child
Figure 13. Global Vaccine Market: For Child (2019-2024) & ($ Millions)
Figure 14. Global Vaccine Market Size Market Share by Application in 2023
Figure 15. Global Vaccine Revenue Market Share by Player in 2023
Figure 16. Global Vaccine Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Vaccine Market Size 2019-2024 ($ Millions)
Figure 18. APAC Vaccine Market Size 2019-2024 ($ Millions)
Figure 19. Europe Vaccine Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Vaccine Market Size 2019-2024 ($ Millions)
Figure 21. Americas Vaccine Value Market Share by Country in 2023
Figure 22. United States Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Vaccine Market Size Market Share by Region in 2023
Figure 27. APAC Vaccine Market Size Market Share by Type in 2023
Figure 28. APAC Vaccine Market Size Market Share by Application in 2023
Figure 29. China Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Vaccine Market Size Market Share by Country in 2023
Figure 36. Europe Vaccine Market Size Market Share by Type (2019-2024)
Figure 37. Europe Vaccine Market Size Market Share by Application (2019-2024)
Figure 38. Germany Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Vaccine Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Vaccine Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Vaccine Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Vaccine Market Size 2025-2030 ($ Millions)
Figure 52. APAC Vaccine Market Size 2025-2030 ($ Millions)
Figure 53. Europe Vaccine Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Vaccine Market Size 2025-2030 ($ Millions)
Figure 55. United States Vaccine Market Size 2025-2030 ($ Millions)
Figure 56. Canada Vaccine Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Vaccine Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Vaccine Market Size 2025-2030 ($ Millions)
Figure 59. China Vaccine Market Size 2025-2030 ($ Millions)
Figure 60. Japan Vaccine Market Size 2025-2030 ($ Millions)
Figure 61. Korea Vaccine Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Vaccine Market Size 2025-2030 ($ Millions)
Figure 63. India Vaccine Market Size 2025-2030 ($ Millions)
Figure 64. Australia Vaccine Market Size 2025-2030 ($ Millions)
Figure 65. Germany Vaccine Market Size 2025-2030 ($ Millions)
Figure 66. France Vaccine Market Size 2025-2030 ($ Millions)
Figure 67. UK Vaccine Market Size 2025-2030 ($ Millions)
Figure 68. Italy Vaccine Market Size 2025-2030 ($ Millions)
Figure 69. Russia Vaccine Market Size 2025-2030 ($ Millions)
Figure 70. Spain Vaccine Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Vaccine Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Vaccine Market Size 2025-2030 ($ Millions)
Figure 73. Israel Vaccine Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Vaccine Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Vaccine Market Size 2025-2030 ($ Millions)
Figure 76. Global Vaccine Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Vaccine Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Vaccine Sales Market Share by Country/Region (2023)
Figure 8. Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Vaccine Market Size Market Share by Type in 2023
Figure 10. Vaccine in For Adult
Figure 11. Global Vaccine Market: For Adult (2019-2024) & ($ Millions)
Figure 12. Vaccine in For Child
Figure 13. Global Vaccine Market: For Child (2019-2024) & ($ Millions)
Figure 14. Global Vaccine Market Size Market Share by Application in 2023
Figure 15. Global Vaccine Revenue Market Share by Player in 2023
Figure 16. Global Vaccine Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Vaccine Market Size 2019-2024 ($ Millions)
Figure 18. APAC Vaccine Market Size 2019-2024 ($ Millions)
Figure 19. Europe Vaccine Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Vaccine Market Size 2019-2024 ($ Millions)
Figure 21. Americas Vaccine Value Market Share by Country in 2023
Figure 22. United States Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Vaccine Market Size Market Share by Region in 2023
Figure 27. APAC Vaccine Market Size Market Share by Type in 2023
Figure 28. APAC Vaccine Market Size Market Share by Application in 2023
Figure 29. China Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Vaccine Market Size Market Share by Country in 2023
Figure 36. Europe Vaccine Market Size Market Share by Type (2019-2024)
Figure 37. Europe Vaccine Market Size Market Share by Application (2019-2024)
Figure 38. Germany Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Vaccine Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Vaccine Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Vaccine Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Vaccine Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Vaccine Market Size 2025-2030 ($ Millions)
Figure 52. APAC Vaccine Market Size 2025-2030 ($ Millions)
Figure 53. Europe Vaccine Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Vaccine Market Size 2025-2030 ($ Millions)
Figure 55. United States Vaccine Market Size 2025-2030 ($ Millions)
Figure 56. Canada Vaccine Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Vaccine Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Vaccine Market Size 2025-2030 ($ Millions)
Figure 59. China Vaccine Market Size 2025-2030 ($ Millions)
Figure 60. Japan Vaccine Market Size 2025-2030 ($ Millions)
Figure 61. Korea Vaccine Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Vaccine Market Size 2025-2030 ($ Millions)
Figure 63. India Vaccine Market Size 2025-2030 ($ Millions)
Figure 64. Australia Vaccine Market Size 2025-2030 ($ Millions)
Figure 65. Germany Vaccine Market Size 2025-2030 ($ Millions)
Figure 66. France Vaccine Market Size 2025-2030 ($ Millions)
Figure 67. UK Vaccine Market Size 2025-2030 ($ Millions)
Figure 68. Italy Vaccine Market Size 2025-2030 ($ Millions)
Figure 69. Russia Vaccine Market Size 2025-2030 ($ Millions)
Figure 70. Spain Vaccine Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Vaccine Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Vaccine Market Size 2025-2030 ($ Millions)
Figure 73. Israel Vaccine Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Vaccine Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Vaccine Market Size 2025-2030 ($ Millions)
Figure 76. Global Vaccine Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Vaccine Market Size Market Share Forecast by Application (2025-2030)
